GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ExpreS2ion Biotech Holding AB (OSTO:EXPRS2) » Definitions » Net Policyholder Benefits/Claims

ExpreS2ion Biotech Holding AB (OSTO:EXPRS2) Net Policyholder Benefits/Claims


View and export this data going back to 2016. Start your Free Trial

What is ExpreS2ion Biotech Holding AB Net Policyholder Benefits/Claims?

Net Policyholder Benefits/Claims only applies to insurance companies.


ExpreS2ion Biotech Holding AB Business Description

Traded in Other Exchanges
N/A
Address
c/o Mindpark, Ronnowsgatan 8c, Helsingborg, SWE, 252 25
ExpreS2ion Biotech Holding AB is a biotechnology company that develops vaccines. It has developed a human clinical Phase III-validated technology platform, ExpreS2, for fast and efficient development and production of the active material in vaccines. The platform, under the brand GlycoX-S2, includes functionally modified glycosylation variants for enhanced immunogenicity and pharmacokinetics. Its product pipeline comprises ES2B-C001, a HER2-VLP-based vaccine in development for human breast cancer therapy; ES2B-I002, a Cytomegalovirus (CMV) vaccine; and several exploratory vaccine projects targeting pathways validated by commercial monoclonal antibody products. Geographically, the company operates in the Nordics region and also has a presence in other countries.